# DART Ventures

> DART Ventures is a VC fund in Zürich backing Health Care and Software. See 21 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Zürich, Switzerland
- Total investments: 21
- Last investment: Sep 2025
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/dartlabs
- X (Twitter): https://twitter.com/DARTtweeting
- Website: http://dartlabs.io
- Facebook: https://www.facebook.com/DARTfacing

DART Ventures is a VC fund in Zürich focused on Health Care and Software. We invest in breakthrough technologies that positively impact health and climate.We put founders first. Our 12-month US expansion program guides startups on strategy, culture, fundraising, and GTM. Startups get experienced partners and their network, as part of their extended team. We invest in founders working on solutions to fundamentallyimprove health and climate. We believe that combining purpose and profit leads to impact.

## Contacts

5 contacts available for DART Ventures. Shizune tracks 5 team members at DART Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/dart-17?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 24% |
| Software | 4 | 19% |
| Virtual Reality | 3 | 14% |
| Artificial Intelligence | 3 | 14% |
| Medical | 2 | 10% |

53 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 9 | 43% |
| Pre-Seed | 5 | 24% |
| Convertible Note | 2 | 10% |
| Non-equity Assistance | 1 | 5% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 12 | 57% |
| United States | 2 | 10% |
| Germany | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Arijana Walcott | Co-Founder & CEO Switzerland | 3 | https://shizune.co/investors/profile/arijana-walcott |
| Aimée Leifer | Venture Partner | 4 | https://shizune.co/investors/profile/aimee-leifer |
| Andrej Kostresevic | Partner; Technology and Ventures | 0 | https://shizune.co/investors/profile/andrej-kostresevic |
| Doug Griffin | Venture Partner | 1 | https://shizune.co/investors/profile/doug-griffin |
| Sophie Lamparter | Managing Partner | 1 | https://shizune.co/investors/profile/sophie-lamparter |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PeriVision | Perivision combines artificial intelligence, virtual reality, and the cloud to build the next generation of systems to understand visual function. The company's systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases. | $3M | Seed | Sep 11, 2025 |  |
| Testmate Health | Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home. | $6M | Seed | May 02, 2024 |  |
| Testmate Health | Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home. |  | Seed | Aug 01, 2023 |  |
| PeriVision | Perivision combines artificial intelligence, virtual reality, and the cloud to build the next generation of systems to understand visual function. The company's systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases. |  | Seed | Jul 18, 2023 |  |
| Resmonics | Resmonics is a spin-off from ETH Zürich and University St. Gallen that has been founded in October 2020. The core of our products is a privacy-friendly acoustic artificial intelligence that analyzes the soundscape in any given room with a focus on detecting symptoms of infectious lung diseases. Our product line, Quorum, combines this AI with airquality sensors and noise analytics to enable healthy and productive working conditions. |  | Pre-Seed | Jun 01, 2023 |  |
| GaeaStar | GaeaStar develops manufacturing and engineering solutions to create geo-neutral products. It offers sustainable processes to eliminate single-use waste. GaeaStar was founded in 2020 and is based in Berlin, Germany. | $6.5M | Seed | Apr 06, 2023 |  |
| Bottneuro | Bottneuro offers a unique, non-invasive therapy for early- and moderate-stage Alzheimer's Disease patients using electrical stimulations of neurons and glia cells in the brain. Bottoneuro develops stimulation protocols using the NENI technology platform. | $4.3M | Convertible Note | Dec 15, 2022 |  |
| Wyth | Wyth creates private digital spaces for virtual and hybrid audiences. With our fully customizable platform organizations can build a seamless experience and an online home for their communities to connect, learn, work, share and play without ever leaving Wyth. We give our customers full control over their brand experience, data ownership andbusiness relationships. | $1.6M | Pre-Seed | Jul 15, 2022 |  |
| Wyth | Wyth creates private digital spaces for virtual and hybrid audiences. With our fully customizable platform organizations can build a seamless experience and an online home for their communities to connect, learn, work, share and play without ever leaving Wyth. We give our customers full control over their brand experience, data ownership andbusiness relationships. | $1.9M | Seed | Jul 07, 2022 |  |
| We Play Sport | We Play Sport aims to develop its product in a number of leagues across multiple targeted geographies during the first half of 2022 to test user engagement and refine its product in readiness for further commercial deployment. |  | Seed | Apr 21, 2022 |  |

10 of 21 investments shown.

## Co-investors
- [DAA Ventures](https://shizune.co/investors/profile/daa-capital-partners) — VC Fund, 3 deals together
- [Privilège Ventures](https://shizune.co/investors/profile/privilege-ventures) — VC Fund, 3 deals together
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund, 3 deals together
- [Gentian Investments](https://shizune.co/investors/profile/gentian-investments) — VC Fund, 2 deals together
- [Zühlke Ventures AG](https://shizune.co/investors/profile/zuhlke-ventures-ag) — VC Fund, 2 deals together
- [Amboy Street Ventures](https://shizune.co/investors/profile/amboy-street-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does DART Ventures invest in?

DART Ventures invests primarily in Health Care, Software and Virtual Reality startups, most often at Seed and Pre-Seed stage. Most of the 21 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact DART Ventures?

Public channels for DART Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at DART Ventures?

The team at DART Ventures includes Arijana Walcott (Co-Founder & CEO Switzerland), Aimée Leifer (Venture Partner) and Andrej Kostresevic (Partner; Technology and Ventures). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co